X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload


EM Imaging radiopharmaceuticals portfolio

Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.

PET Imaging


Indications to be disclosed at a later stage.

Edinburgh Molecular Imaging – 2021